PubMed:32560744 / 3236-3556 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T18","span":{"begin":231,"end":236},"obj":"GO:0016265"},{"id":"T19","span":{"begin":265,"end":270},"obj":"NCBITaxon:10239"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"But may include; time to clinical improvement of at least 2 points on the WHO 9-point category ordinal scale [measured up to 29 days from randomisation], progression of disease (oxygen saturation (SaO2) \u003c92%) or hospitalization or death, or change in time-weighted viral load [measured up to 29 days from randomisation]."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":103,"end":108},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"But may include; time to clinical improvement of at least 2 points on the WHO 9-point category ordinal scale [measured up to 29 days from randomisation], progression of disease (oxygen saturation (SaO2) \u003c92%) or hospitalization or death, or change in time-weighted viral load [measured up to 29 days from randomisation]."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T23","span":{"begin":197,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0008947"},{"id":"T24","span":{"begin":197,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0050140"}],"text":"But may include; time to clinical improvement of at least 2 points on the WHO 9-point category ordinal scale [measured up to 29 days from randomisation], progression of disease (oxygen saturation (SaO2) \u003c92%) or hospitalization or death, or change in time-weighted viral load [measured up to 29 days from randomisation]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":178,"end":184},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"But may include; time to clinical improvement of at least 2 points on the WHO 9-point category ordinal scale [measured up to 29 days from randomisation], progression of disease (oxygen saturation (SaO2) \u003c92%) or hospitalization or death, or change in time-weighted viral load [measured up to 29 days from randomisation]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T27","span":{"begin":0,"end":320},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"But may include; time to clinical improvement of at least 2 points on the WHO 9-point category ordinal scale [measured up to 29 days from randomisation], progression of disease (oxygen saturation (SaO2) \u003c92%) or hospitalization or death, or change in time-weighted viral load [measured up to 29 days from randomisation]."}